
Prasudoc 5mg Tablet
Marketer
Lupin Ltd
Salt Composition
Prasugrel (5mg)
Overview Prasudoc 5mg Tablet
CardioGuard 5mg tablets are antiplatelet agents, also known as blood thinners. They work by inhibiting the formation of dangerous blood clots, ensuring smooth blood flow. This reduces the risk of recurrent heart attacks or strokes in patients with cardiovascular disease. CardioGuard 5mg is indicated for individuals who have recently experienced a heart attack or severe angina, particularly those who have received a coronary stent. It helps prevent serious cardiac events such as repeat heart attacks, strokes, or stent thrombosis. This medication is often prescribed alongside aspirin, another antiplatelet drug. It can be administered with or without food, but consistent daily dosing at the same time is crucial. Continued use is vital, even during periods of well-being; discontinuation increases the risk of cardiovascular events. The most prevalent adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be prolonged. While most bleeding episodes are minor and self-limiting, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in patients with active bleeding (e.g., peptic ulcer, intracranial hemorrhage), or severe hepatic impairment. Prior to commencing treatment, inform your physician of any history of bleeding disorders, recent major trauma, or upcoming surgery. CardioGuard may require temporary cessation before scheduled procedures.
Primary Ingredients of Prasudoc 5mg Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Prasudoc 5mg Tablet
Avoiding Heart Attacks and Strokes
Major Benefits of Prasudoc 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Prasudoc tablet whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistency in timing is recommended.
Common Side effects of Prasudoc 5mg Tablet:
- Bleeding
How to use Prasudoc 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Prasudoc tablet whole; avoid crushing, chewing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.
How Prasudoc 5mg Tablet works:
CardioGuard 5mg tablets offer antiplatelet action, inhibiting platelet aggregation to reduce the risk of dangerous clot development. This significantly lowers the likelihood of recurrent stroke or myocardial infarction.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Prasudoc 5mg tablets presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Data on Prasudoc 5mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Prasudoc 5mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Prasudoc 5mg Tablets.
KidneySAFE IF PRESCRIBED
Prasudoc 5mg tablets appear to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary, though this is based on limited information. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Prasudoc 5mg Tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Data on Prasudoc 5mg Tablet use in such patients is limited. Dose alteration isn't advised for those with mild to moderate liver dysfunction.
What if you forget to take Prasudoc 5mg Tablet :
Should you forget a Prasudoc 5mg Tablet dose, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Prasudoc 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-based compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | ADP receptor antagonists (P2Y12 inhibitors) |
